Skip to content

Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries

Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00385866
Enrollment
1272
Registered
2006-10-11
Start date
2006-10-31
Completion date
2010-12-31
Last updated
2016-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Patient Navigator, Community health, Communication

Brief summary

To reduce Cancer health care disparities that exists among minority Medicare beneficiaries and to demonstrate cost effectiveness of patient navigation in reducing the burden of cancer.

Detailed description

The Latino population is the fastest growing minority population in the United States . Cancer ranks as the second leading cause of death among Latinos in the United States (24%), second only to heart disease . This project will evaluate whether an innovative facilitation program (targeting cancers of the prostate, colon/rectum, breast, and cervix) will improve cancer outcomes among Latino Medicare beneficiaries in the city of Newark, New Jersey. The overall aim of this project is to institute an innovative cancer care facilitation program for elderly Latinos in the city of Newark, NJ. The goal is to reduce the disparities observed in screening, time to diagnosis and treatment services, by utilizing a multidisciplinary team approach to health care, incorporating systems thinking methodology. Using the Multilevel Approach to Community Health (MATCH) planning model , the program will incorporate community outreach, education, and access to screening, and patient assistance in all aspects of the health care continuum. It will also include cultural and linguistic competency training for all those involved in the facilitation process. To accomplish this goal, we propose four objectives: 1. To establish a multidisciplinary team that will utilize a systems thinking approach to design and structure the delivery of cancer screening, diagnosis and treatment facilitation services. 2. To build a collaborative consortium between program partners to improve screening outcomes, that will encourage the utilization of services in the community. 3. To improve the delivery of cancer prevention and treatment facilitation by providing cultural and linguistic competency training to the multidisciplinary team, providers, and the community. 4. To demonstrate the effectiveness of the intervention in reducing the burden of cancer, by increasing screening rates, improving time to diagnosis and delivery of treatment services, patient satisfaction, and appropriate use of Medicare services.

Interventions

BEHAVIORALcancer screening and health education

The control group will receive cancer screening and health education materials on a quarterly basis but will not have access to patient navigation services.

BEHAVIORALfacilitation of Services to improve cancer screening

The intervention group will receive cancer education and faciliation of services in the form of patient navigation

Sponsors

Centers for Medicare and Medicaid Services
CollaboratorFED
University of Medicine and Dentistry of New Jersey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Cancer-Negative Group 1. Be of Hispanic/Latino Origin 2. Fluent in English and/or Spanish 3. Recipient of, Medicare Part A & B, or combined Medicare/Medicaid 4. Not having a previous diagnosis of cancer 5. Be capable of giving written informed consent prior to any study related procedures. 6. Be available and willing to complete all study assessments as specified. Cancer-Positive Group 1. Be of Hispanic/Latino Origin 2. Fluent in English and/or Spanish 3. Recipient of, Medicare Part A & B, or combined Medicare/Medicaid 4. Having a previous diagnosis of cancer of the breast, cervix, colon and/or rectum, prostate, or lung. 5. Be capable of giving written informed consent prior to any study related procedures. 6. Be available and willing to complete all study assessments as specified.

Exclusion criteria

1. Member of the Medicare Advantage Plan, any Medicare managed care plan (Those who join the Medicare Advantage plan or a managed care plan during the course of the study will become ineligible to continue.) 2. Medicaid only beneficiaries 3. Institutionalized 4. Unable to provide written informed consent

Design outcomes

Primary

MeasureTime frame
Reduce the disparities observed in utilization of cancer screening services2-4 years

Secondary

MeasureTime frame
Improve the time to diagnosis and treatment services (resulting in reduced cost of cancer care4 years
Improve patient satisfaction and informed decision making.4 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026